Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-10

Clinical Trial Update: Clinical Feasibility Study of Allium's Biliary Stent [NA]

View source ↗

Summary

The clinical feasibility study for Allium's biliary stent in malignant obstruction of the common bile duct has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allium biliary stent

Snippet

Sponsor: Allium, Ltd. | Conditions: Malignant Obstruction of the Common Bile Duct | NA | Status: WITHDRAWN